TriSalus Life Sciences makes the TriNav medical device and sells it mainly to hospitals and physicians. TLSI reports earnings on Tue, Nov 10, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 23 | HC Wainwright & Co. | Target raised | Buy | |
| Sep 9 | HC Wainwright & Co. | Initiated | Buy |
Seasonality
How TLSI has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
Whale Options Flow
90DNo whale options trades in TLSI in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TLSI is in one of them and how their past TLSI trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered TLSI in an article yet. Here's the latest on the wider market.
About TriSalus Life Sciences
TriSalus Life Sciences is a medical device company based in Westminster, Colorado. It sells its TriNav device to hospitals and physicians, often through consignment agreements. The company is also developing other products that are still in preclinical studies and clinical trials. Its customers are mainly hospitals and the physicians who use its products to treat patients.
- Headquarters
- Westminster, CO